55lst MEETING, ST. ANDREWS 1215 fatty acid synthesis. This ratio was higher in obese mice than that of non-obese mice when the source of 14C was glucose or fructose, whereas the same ratio was lower in the presence of alanine. This suggests that unlabelled carbon atoms derived from glycolysis were proportionately more readily available in obese adipose tissue, but also that there was altogether a lower contribution of endogenous acetyl-CoA in the same tissue.
The Physiological Role of Fatty Acid Elongation in Particulate Fractions of Rat Liver and Relative Control Factors
In liver cells fatty acid synthesis de novo is carried out by soluble enzymes producing essentially palmitic acid (Porter 8~ Tietz, 1957) . In this tissue, besides synthesis de novo two other systems, one associated with microsomal fractions (Nugteren, 1965) and the other with mitochondria (Harlan & Wakil, 1963; Quagliariello et al., 1968) , have been shown to catalyse chain elongation, producing a variety of saturated and unsaturated fatty acids. Up to now the physiological role of these two systems, as well as their possible control factors, have not been extensively investigated. In the present research, by using combined systems (cell sap plus microsomal fraction and cell sap plus mitochondria), we have attempted a qualitative and quantitative evaluation of their capacity to elongate palmitic acid de nouo formed by soluble synthetase (Landriscina et a/., 1972). By incubating rat liver cell sap and niicrosomal fraction together, it has been found that the amount of palmitic acid synthesized from [1,3-14C]malonyl-CoA decreases by about 30% with respect to that obtained in the presence of cell sap alone, with a concomitant equal increase of stearic acid, oleic acid, arachidic acid and other fatty acids higher than Czo (Table 1) . It is also important to emphasize that elongation by microsomal fractions has been observed to be strictly dependent on the presence of ATP in the reaction mixture. Our interpretation of this requirement is that the final product of fatty acid synthetase (palmitic acid) is released as free. acid by palmityl thioesterase (Barnes & Wakil, 1968) , so that ATP is necessary for its CoA ester-derivative formation, before further utilization. This assumption has been confirmed by the finding that after incubation of [l-14C] palmitoyl-CoA with cell sap plus microsomal fraction, in identical experimental conditions, a pattern of labelled fatty acids similar to that previously described is obtained (Table 1) . Another aspect to be mentioned is that in the presence of the microsomal fraction and ATP, fatty acids synthesized by cell sap are found to be almost totally esterified into phospholipids. In the absence of ATP no esterification occurs and only free fatty acids are found.
When cell sap and mitochondria are incubated togetlm in the presence of ATP, the pattern of synthesized fatty acids does not greatly differ from that obtained by cell sap been verified that it is not due to microsomal contamination.
Effect of cyclic AMP on fatty acid synthesis
Recently a possible role of cyclic AMP as a part of the messenger system by which lipid metabolism can be regulated (Allred & Roehrig, 1973a) has been suggested. Although evidence has been accumulated indicating that adenosine 3': 5'-cyclic monophosphate inhibits hepatic lipogenesis both in vitro (Bricker & Levey, 1972) and in uivo (Rous, 1970) , up to now the site of cyclic AMP inhibition of this metabolism has not been established. Allred & Roehrig (1973b) have shown that a major portion of the inhibition of lipogenesis in rat liver by cyclic AMP is attributable to inhibition of acetylCoA carboxylase. We have tested to see if adenosine 3': 5'-cyclic monophosphate has some effect on the crude rat liver fatty acid synthetase and the chainelongation systems present in mitochondria and microsomal fraction. The results we obtained indicate that incorporation of [1,3-14C]malonyl-CoA by fatty acid synthetase is inhibited by about 40% by 3m~cyclic AMP and this inhibition increases by increasing the concentration of cyclic nucleotide (Table 3) . Compared with synthesis de novo, microsomal chain elongation of fatty acids, at the same cyclic AMP concentrations, is less affected. In fact at 3m-cyclic AMP, microsomal activity is decreased by about 30%. The other chainelongation system operating in liver, which is present in mitochondria, is not significantly affected at concentrations of cyclic AMP up to lOmM (Table 3) .
Efect of clofbrate on fatty acid synthesis
As the mode of action of clofibrate (a hypolipidaemic drug) on lipid metabolism has not yet been definitively established, another aspect of the present investigation was to check whether this drug in vitro has some effect on the cell-sap fatty acid synthetase and chain-elongation systems associated with particulate fractions of rat liver. Table 3 shows that palmitate formation de novo from [1,3-14C] malonyl-CoA in cell sap is inhibited by about 26% at 5mM drug concentration. The inhibition increases by increasing the VOl. 2 concentration of this compound and reaches 38.8 % at 19m~-clofibrate. Table 3 also shows that microsomal chain elongation is significantly inhibited from 2 . 5 m~ on and at concentrations higher than 9 . 5 m~ is almost completely depressed. In comparison mitochondria1 chain-elongation synthesis is poorly affected by clofibrate at conccntrations ranging from 2.5 to 1 9 . 0 m~.
Conclusions
The results indicate that by combining cell sap with microsomal fraction, the microsoma1 fraction actively elongates and desaturates the palmitate synthesized de novo by the soluble system. The fatty acids produced by this combined system are esterified principally into phospholipids. Both the elongation and esterification processes require ATP. Under identical experimental conditions, the activity of the chainelongation and esterification processes of mitochondria are 20 % of those detected in microsomal fractions. Therefore it seems that in rat liver, the microsomal fraction is the main site for the formation of long-chain saturated and unsaturated fatty acids.
Concerning the control mechanisms of the two elongation systems the present evidence indicates that cyclic AMP, at least in vitro, does not affect this enzymic activity. As chain elongation is strictly dependent on ATP, we would suggest that the ATP concentration in animal cells represents the control for the elongation and/or esterification step of newly formed fatty acids.
Finally our data point out that the hypolipidaemiceffect of clofibrate, besidesinhibition of formation of palmitate de novo, may be due to a decreased microsomal synthesis of show the positions of the saturated methyl esters.
